Life Sciences Fund Description • Target investments at the intersection of life sciences and technology including: o Early detection and prevention of cancer and other diseases o Molecular diagnostics and personalized medicine o Consumer/patient empowerment • Target fund size: $250-400m • Term: 10 years • Expected Launch: January 2014 Structure • Branding: DST • Three partners: DST, Boris Nikolic and Saurabh Gupta o Boris and Saurabh will be Managing Partners • GP contribution: DON of fund size • Joint decision making • Operational support to be provided by DST Global Advisors Economics • Carried interest split: o DST — 50% o Boris Nikolic — 25% o Saurabh Gupta — 25% • Management fee share: o Boris Nikolic to receive 100% of all fees (less expenses) on the first $5m of fees o All fees beyond the first $5m (less any remaining expenses) to be split in line with carried interest Key LP Terms • $10m+ capital commitment • 2.0% management fee and 20% carried interest on net returns Key Investment Terms • Non-controlling investments • Founder friendly terms STRICTLY CONFIDENTIAL EFTA_R1_0041221 5 EFTA01948118